Publications:

β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.

Molecular Cancer Research : Mcr

Kallifatidis, Georgios G; Munoz, Daniel D; Singh, Rajendra Kumar RK; Salazar, Nicole N; Hoy, James J JJ; Lokeshwar, Bal L BL

Publication Date: 2016-05

Variant appearance in text: EGFR: Y1110F

PubMed Link: 26921391

Variant Present in the following documents:

• Main text

View BVdb publication page

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.

Oncotarget

Kim, Nayoung N; Cho, Ahye A; Watanabe, Hideo H; Choi, Yoon-La YL; Aziz, Meraj M; Kassner, Michelle M; Joung, Je-Gun JG; Park, Angela Kyung-Joo AK; Francis, Joshua M JM; Bae, Joon Seol JS; Ahn, Soo-Min SM; Kim, Kyoung-Mee KM; Park, Joon Oh JO; Park, Woong-Yang WY; Ahn, Myung-Ju MJ; Park, Keunchil K; Koo, Jaehyung J; Yin, Hongwei Holly HH; Cho, Jeonghee J

Publication Date: 2016-03-22

Variant appearance in text: EGFR: Y1110F

PubMed Link: 26883194

Variant Present in the following documents:

• Main text
• oncotarget-07-13797.pdf

View BVdb publication page